NCT00166426View on ClinicalTrials.gov

Exisulind Versus Placebo After Surgical Removal of the Prostate

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2008

Conditions

Prostatic Neoplasms

Interventions

DRUG

Exisulind

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

OSI Pharmaceuticals

All Listed Sponsors

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00166426 - Exisulind Versus Placebo After Surgical Removal of the Prostate | Biotech Hunter | Biotech Hunter